Azora Therapeutics Quarterly Balance Sheet
NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Azora Therapeutics financial position
As of Sep 30, 2026, Azora Therapeutics reported total assets of $22.5 million, up 298.0% from a year earlier against total liabilities of $5.1 million. Shareholders' equity was negative at -$21.1 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $22.0 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 4.43, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Azora Therapeutics balance sheet (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q2 20242024-03-31 | Q4 20232023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 22.00M | 28.71M | 4.58M | 5.88M | 4.61M | 5.91M | 2.37M | 3.75M | 5.20M | 3.29M | 5.03M | 2.83M |
| Total Current Assets | 22.38M | 28.84M | 4.80M | 6.18M | 5.01M | 6.08M | 2.63M | 4.06M | 5.62M | 3.82M | — | 3.20M |
| Intangible Assets | 3.00K | 3.00K | 2.64K | 3.00K | 2.92K | 3.07K | 3.21K | 3.35K | 3.49K | 3.63K | — | 3.91K |
| Total Assets | 22.53M | 29.09M | 5.23M | 6.67M | 5.66M | 6.80M | 3.45M | 5.04M | 6.71M | 4.95M | — | 4.74M |
| Accounts Payable | 1.39M | 2.62M | 573.57K | 655.00K | 556.28K | 671.12K | 532.43K | 250.13K | 318.12K | 316.73K | — | 103.33K |
| Total Current Liabilities | 5.06M | 5.12M | 1.51M | 1.40M | 1.15M | 1.21M | 1.32M | 975.86K | 829.05K | 671.88K | — | 653.08K |
| Total Liabilities | 5.06M | 28.93M | 1.51M | 1.40M | 1.15M | 1.21M | 1.32M | 975.86K | 829.05K | 671.88K | — | 653.08K |
| Shareholders' Equity | -21.06M | -38.38M | 3.72M | 5.28M | 4.50M | 5.59M | 2.13M | 4.07M | 5.88M | 4.28M | 6.12M | 4.08M |
| Retained Earnings | -208.55M | -143.98M | -91.99M | -89.97M | -87.98M | -86.18M | -84.22M | -82.00M | -79.92M | -77.73M | — | -68.80M |
| Net Cash (Debt) | 22.00M | 28.71M | 4.58M | 5.88M | 4.61M | 5.91M | 2.37M | 3.75M | 5.20M | 3.29M | 5.03M | 2.83M |
| Shares Outstanding | 2.63M | 2.63M | 1.51M | 1.11M | 23.84M | 21.53M | 6.65M | 258.83K | 6.41M | 4.29M | — | 1.66M |
This table shows 12 quarterly periods of Azora Therapeutics's balance sheet, from Q3 2026 back to Q4 2023, across 13 line items including cash & equivalents, total current assets, property, plant & equipment. Values in USD; B = billions, M = millions. Fiscal periods follow AZR's reporting calendar. What is a balance sheet?